Dynamic Metabolic Changes during the First 3 Months after 90Y-Ibritumomab Tiuxetan Radioimmunotherapy
Figure 4
Maximum intensity projection images of patient 3. (a) Baseline, (b) 1-week scan, (c) 4-week scan, and (d) 12-week scan. FDG-avid lesions (arrow) are seen in bilateral subclavicular, axillary, abdominal para-aortic, and left inguinal area at baseline. Decrease in metabolism is observed at 1 week. All lesions continued to decrease to 12 weeks. At 12 weeks, only slight accumulation in the right axillary lesion is visible. Physiological activities are seen in the liver and the urinary tract.
